Allerkan

Allerkan

betamethasone

Manufacturer:

S Kant Healthcare

Distributor:

International Apex
Concise Prescribing Info
Contents
Betamethasone dipropionate
Indications/Uses
Relief of inflammatory & pruritic manifestations of corticosteroid-responsive dermatoses in patients ≥13 yr.
Dosage/Direction for Use
Apply a thin film to the affected skin area once daily or bid. Should be limited to 50 g/wk.
Contraindications
Hypersensitivity to betamethasone or other corticosteroids.
Special Precautions
Not to be used w/ adhesive dressings. Avoid contact w/ eyes. May produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia & glucosuria; dermatological infections. Systemic toxicity. Discontinue use & institute appropriate therapy if irritation develops. Concomitant use w/ potent corticosteroid-containing product. Prolonged use. HPA axis suppressions, Cushing's syndrome & intracranial HTN in childn. Treated skin should not be bandaged or covered or wrapped; not to use tight-fitting diapers or plastic pants on infants. Do not use during pregnancy. Lactation.
Adverse Reactions
Burning, itching-irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, miliaria.
ATC Classification
D07AC01 - betamethasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.
Presentation/Packing
Form
Allerkan cream 0.05%
Packing/Price
15 g x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in